BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2019
View Archived Issues
Tetraphase Pharmaceuticals presents TP-2846 for leukemia therapy
Read More
TAK-169 shows promising activity in models of CD38-expressing multiple myeloma
Read More
Highly selective PIKdelta inhibitor IOA-244 has preclinical efficacy in cancer models
Read More
M-4076 enhances the efficacy of radiotherapy in preclinical models
Read More
Initiation of phase I/II study of OTO-313 in patients with tinnitus
Read More
Pragma Therapeutics discovers mGlu7 receptor antagonists
Read More
New Janus kinase inhibitors described by Beijing Scitech-Mq Pharmaceuticals
Read More
Takeda discovers hypoxia-inducible factor prolyl hydroxylase inhibitors
Read More
Channel Therapeutics identifies P. aeruginosa transcriptional activator protein LasR inhibitors
Read More
Patient enrollment ongoing in phase I NeoPepVac study
Read More
Lead Discovery Center and collaborators patent coumarin derivatives
Read More
Orbsen initiates treatment in MERLIN study of its second-generation immunotherapy ORBCEL-C
Read More
Rubius Therapeutics reports new allogeneic RBCs for treating solid tumors
Read More
Mallinckrodt, Washington University to jointly search for drugs targeting chronic itch
Read More
University of Louisville and Qualigen to develop RAS inhibitor candidates
Read More
GlaxoSmithKline enrolling in first-in-human study of GSK-3745417 for advanced solid tumors
Read More
Evotec and Exscientia detail discovery of EVOEXS-21546 for cancer immunotherapy
Read More
FDA approves expanded monotherapy label for Keytruda in first-line NSCLC
Read More
Autophagy disruption affects social behavior in mice
Read More
TATTON study results reported for osimertinib with selumetinib or savolitinib in EGFR-mutant NSCLC
Read More
Tracon terminates for futility phase III TAPPAS trial of TRC-105 in angiosarcoma
Read More
AUT-00206 reduces ketamine-induced BOLD response in phase Ib study
Read More
Sernova conducts first Cell Pouch transplant in U.S. phase I/II trial for type 1 diabetes
Read More
